These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 23428480)

  • 1. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
    Shityakov S; Neuhaus W; Dandekar T; Förster C
    Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method.
    Narayanan R; Gunturi SB
    Bioorg Med Chem; 2005 Apr; 13(8):3017-28. PubMed ID: 15781411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands.
    Nikolic K; Filipic S; Smoliński A; Kaliszan R; Agbaba D
    J Pharm Pharm Sci; 2013; 16(4):622-47. PubMed ID: 24210068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico prediction of blood brain barrier permeability: an Artificial Neural Network model.
    Garg P; Verma J
    J Chem Inf Model; 2006; 46(1):289-97. PubMed ID: 16426064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes.
    Zhao YH; Abraham MH; Ibrahim A; Fish PV; Cole S; Lewis ML; de Groot MJ; Reynolds DP
    J Chem Inf Model; 2007; 47(1):170-5. PubMed ID: 17238262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties.
    Hou TJ; Zhang W; Xia K; Qiao XB; Xu XJ
    J Chem Inf Comput Sci; 2004; 44(5):1585-600. PubMed ID: 15446816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prediction model for blood-brain barrier permeation and analysis on its parameter biologically.
    Chen Y; Zhu QJ; Pan J; Yang Y; Wu XP
    Comput Methods Programs Biomed; 2009 Sep; 95(3):280-7. PubMed ID: 19473718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery.
    Vandenhaute E; Sevin E; Hallier-Vanuxeem D; Dehouck MP; Cecchelli R
    Drug Discov Today; 2012 Apr; 17(7-8):285-90. PubMed ID: 22033197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-silico prediction of blood-brain barrier permeability.
    Yan A; Liang H; Chong Y; Nie X; Yu C
    SAR QSAR Environ Res; 2013 Jan; 24(1):61-74. PubMed ID: 23092117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of brain and CSF permeation of small molecules using PLS regression models.
    Bendels S; Kansy M; Wagner B; Huwyler J
    Eur J Med Chem; 2008 Aug; 43(8):1581-92. PubMed ID: 18206268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods.
    Li H; Yap CW; Ung CY; Xue Y; Cao ZW; Chen YZ
    J Chem Inf Model; 2005; 45(5):1376-84. PubMed ID: 16180914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico model of drug permeability across sublingual mucosa.
    Goswami T; Kokate A; Jasti BR; Li X
    Arch Oral Biol; 2013 May; 58(5):545-51. PubMed ID: 23123066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling blood-brain barrier partitioning using Bayesian neural nets.
    Winkler DA; Burden FR
    J Mol Graph Model; 2004 Jul; 22(6):499-505. PubMed ID: 15182809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the utility of momentum-space descriptors for predicting blood-brain barrier penetration.
    Al-Fahemi JH; Cooper DL; Allan NL
    J Mol Graph Model; 2007 Oct; 26(3):607-12. PubMed ID: 17300970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapidly profiling blood-brain barrier penetration with liposome EKC.
    Wang Y; Sun J; Liu H; He Z
    Electrophoresis; 2007 Jul; 28(14):2391-5. PubMed ID: 17578839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting blood-brain barrier permeation from three-dimensional molecular structure.
    Crivori P; Cruciani G; Carrupt PA; Testa B
    J Med Chem; 2000 Jun; 43(11):2204-16. PubMed ID: 10841799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar molecular descriptors determine the in vitro drug permeability in endothelial and epithelial cells.
    Hakkarainen JJ; Pajander J; Laitinen R; Suhonen M; Forsberg MM
    Int J Pharm; 2012 Oct; 436(1-2):426-43. PubMed ID: 22750947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage.
    Grumetto L; Russo G; Barbato F
    Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.